Get the weekly note

As of . Rebuilt every trading night.

The biotech ETFs least like the S&P 500

Every fund here is sold on biotech, and they differ in how much of the index they hand you back. The one at the top is the one adding the most that is new.

The biotech ETFs least like the S&P 500, ranked by the share of the fund by weight that is held in S&P 500 companies, as of Sep 18, 2026. Source: ETFIQ.
#TickerFundWeight in S&P 500 companiesActive shareNet assetsFee
1BBCVirtus Biotech Clinical Trials ETF0.0%100.0%$37m0.65%
2BBPVirtus Biotech ETF12.4%99.0%$59m0.34%
3FBTFirst Trust NYSE Arca Biotechnology Inde23.6%99.1%$2.9bn0.55%
4PBEInvesco Biotechnology & Genome ETF30.0%99.0%$414m0.59%
5IBBQInvesco Nasdaq Biotechnology ETF38.6%99.0%$96m0.19%
6PBPHPortfolio Building Block World Pharma an56.8%95.0%$36m0.13%
7BBHVanEck Biotech ETF60.4%99.0%$498m0.35%

Method

The 7 of 7 ETFs in the biotech theme with a filed book, least overlap first, each measured against the S&P 500 holdings ETFIQ reads for the same date. Across the funds listed here the weight held in S&P 500 companies runs from 0.0% to 60.4%. A thematic fund is worth its fee only for the part of it you do not already own. The ranking is the published field sorted, nothing else: no scoring, no weighting and no view on any fund. Every fund ETFIQ covers in this category is eligible, including funds that have closed, because leaving them out would flatter the category.

Where to next

Where these figures came from

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

A ranking is not a recommendation and no order on this site is an opinion. ETFIQ is an independent publisher, not an adviser. Standards and sources

Cite this page. ETFIQ, The biotech ETFs least like the S&P 500, ranked by the share of the fund by weight that is held in S&P 500 companies, data as of Sep 18, 2026. https://etfiq.com/rankings/themes-off-index-biotech Free to use with attribution; the underlying files are at Open data.